Background/aims Up-to-date, stratified estimates of the number of individuals affected by glaucoma in the UK are lacking.

Glaucoma is a major public health issue in ophthalmology. Despite advances in diagnostics and treatment, it continues to be ...

Ocular infections, caused by a variety of microbes, are likely to become more difficult to treat due to the global increase in antimicrobial resistance (AMR). Traditional assays for resistance only ...

Correspondence to Dr Jelle Vehof, Department of Twin Research & Genetic Epidemiology, King's College London, St Thomas’ Hospital, Westminster Bridge Road, London SE1 7EH, UK; j.vehof{at}umcg.nl ...

Background Mutations in the L/M cone opsin gene array cause abnormally high perceived retinal contrast and the development of myopia. Environmental factors may also lead to high visual contrast and ...

2 Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China Background Myopia is a pervasive global public health concern, ...

Paul T Finger, MD, Ocular Tumour Service, New York Eye and Ear Hospital, 310 East 14th Street, New York City, NY 10003, USA. AIM To evaluate topical mitomycin C (MMC) chemotherapy in the treatment of ...

Purpose To develop and validate a deep learning model for the segmentation of five retinal biomarkers associated with neovascular age-related macular degeneration (nAMD). Methods 300 optical coherence ...

Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information. The data that support the findings of this study were made available by ...

Applied Vision Research Centre, The Henry Wellcome Laboratories for Vision Sciences, City University, London, UK Background: The binocular Esterman visual field test (EVFT) is the current visual field ...

Correspondence to Michel Michaelides, UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK; michel.michaelides{at}ucl.ac.uk Background/aims Vitreous haemorrhage (VH) and retinal ...

Background The efficiency of clinical trials for retinitis pigmentosa (RP) treatment is limited by the screening burden and lack of reliable surrogate markers for functional end points. Automated ...